Cargando…
FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide
PURPOSE: Glioma is the most common primary intracranial tumor. Owing to the poor prognosis associated with high-grade gliomas, there is an urgent need to identify biomarkers related to prognosis and treatment sensitivity. Here, we analyze the expression of FXYD2 mRNA in gliomas, and explore its clin...
Autores principales: | Zhou, Kaijia, Jiang, Tao, Liu, Yanwei, Zhao, Zheng, Huang, Lijie, Li, Guanzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576926/ https://www.ncbi.nlm.nih.gov/pubmed/34753441 http://dx.doi.org/10.1186/s12883-021-02476-2 |
Ejemplares similares
-
ABCC8 mRNA expression is an independent prognostic factor for glioma and can predict chemosensitivity
por: Zhou, Kaijia, et al.
Publicado: (2020) -
A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression
por: Zhou, Kaijia, et al.
Publicado: (2020) -
FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer
por: Luo, Wen, et al.
Publicado: (2021) -
What FXYDs fix
por: Habeck, Michael, et al.
Publicado: (2021) -
Radiotherapy delays malignant transformation and prolongs survival in patients with IDH-mutant gliomas
por: Liu, Yanwei, et al.
Publicado: (2022)